Cetera Investment Advisers
PACB icon

Cetera Investment Advisers’s Pacific Biosciences PACB Stock Holding History

Cetera Investment Advisers’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.8K Buy
51,359
+2,416
+5% +$4.32K ﹤0.01% 4538
2025
Q4 		$91.5K Sell
48,943
-101,238
-67% -$195K ﹤0.01% 4423
2025
Q3 		$192K Buy
150,181
+45,456
+43% +$61.6K ﹤0.01% 4163
2025
Q2 		$130K Buy
104,725
+9,617
+10% +$11.1K ﹤0.01% 3841
2025
Q1 		$112K Buy
95,108
+66,776
+236% +$102K ﹤0.01% 3752
2024
Q4 		$51.8K Sell
28,332
-91,167
-76% -$178K ﹤0.01% 3654
2024
Q3 		$203K Buy
119,499
+89,139
+294% +$146K ﹤0.01% 3372
2024
Q2 		$41.6K Sell
30,360
-11,157
-27% -$22.5K ﹤0.01% 3606
2024
Q1 		$156K Buy
41,517
+27,105
+188% +$159K ﹤0.01% 3417
2023
Q4 		$141K Buy
+14,412
New +$118K ﹤0.01% 2103

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return